The sharp 64 percent increase in VMMC observed last year reversed course in 2018. Overall funding decreased by 47 percent falling to US$9.2 million. This drop can be traced back to a 40 percent decline in investment from BMGF, the largest technology-specific donor. BMGF funding fell to US$8.3 million in 2018 but still constituted 90 percent of all investment. US public sector investment also declined from US$3.4 million to US$0.7 million, with the only contribution coming from the NIH.
Sufficient empirical studies have already affirmed the efficacy of VMMC as a prevention option, which is likely why 66 percent of the research is allocated to implementation science and the large-scale rollout of services in underserved populations. Other areas of focus include behavioral and social science research (19 percent), basic (2 percent) and advocacy and policy development (12 percent).
For more, read the full report.